Your browser doesn't support javascript.
loading
Uncovering patterns of inhaler technique and reliever use: the value of objective, personalized data from a digital inhaler.
Levy, Mark L; Kocks, Janwillem W H; Bosnic-Anticevich, Sinthia; Safioti, Guilherme; Reich, Michael; Depietro, Michael; Castro, Mario; Farooqui, Nabeel; Lugogo, Njira L; Brown, Randall; Hill, Tanisha; Li, Thomas; Chrystyn, Henry.
Affiliation
  • Levy ML; General Practitioner, London, UK. bigcatdoc@gmail.com.
  • Kocks JWH; General Practitioners Research Institute, Groningen, Netherlands.
  • Bosnic-Anticevich S; Observational and Pragmatic Research Institute, Midview City, Singapore.
  • Safioti G; Groningen Research Institute Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Reich M; Department of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Depietro M; Woolcock Institute of Medical Research, University of Sydney, Glebe, NSW, Australia.
  • Castro M; Teva Pharmaceuticals Europe B.V., Amsterdam, Netherlands.
  • Farooqui N; Teva Pharmaceutical Industries Ltd, Tel Aviv, Israel.
  • Lugogo NL; Teva Branded Pharmaceutical Products R&D Inc., West Chester, PA, USA.
  • Brown R; Incyte Corporation, Newark, DE, USA.
  • Hill T; Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.
  • Li T; Allergy Partners of Fishers, Indianapolis, IN, USA.
  • Chrystyn H; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
NPJ Prim Care Respir Med ; 34(1): 23, 2024 Aug 20.
Article in En | MEDLINE | ID: mdl-39164292
ABSTRACT
Electronic inhalers provide information about patterns of routine inhaler use. During a 12-week study, 360 asthma patients using albuterol Digihaler generated 53,083 inhaler events that were retrospectively analyzed. A total of 41,528 (78%) of the recorded inhalation events were suitable for flow analysis (having a PIF ≥ 18 L/min and <120 L/min). Median PIF, inhalation volume, inhalation duration, and time to PIF for these events steadily decreased between the first and last 10 days of the study, by 5.1%, 12.6%, 15.9%, and 6.4%, respectively. Continuous short-acting beta2-agonist (SABA) overuse, defined as ≥2 SABA inhalations/week throughout the study period, was seen in 29% (n = 104) of patients. Of 260 patients with ≥1 instance of acute short-term SABA overuse, 55 (21%) had a confirmed exacerbation. Electronic recording of real-life inhaler use can capture valuable, objective information that could inform disease management and clinical decision-making.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Nebulizers and Vaporizers Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: NPJ Prim Care Respir Med Year: 2024 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Nebulizers and Vaporizers Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: NPJ Prim Care Respir Med Year: 2024 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom